Is it end of inhalable exubera In October 2007, Pfizer, one of the largest global pharmaceutical companies, took the market by surprise by announcing its decision to discontinue the production of Exubera [rDNA origin], the inhalable powder formulation of insulin for the...
Diabetes Experts Recommend One-Two Punch for Treating Patients with Pre-Diabetes - For the first time, a consensus of diabetes and metabolic disorder experts have recommended a comprehensive treatment regimen for patients with pre-diabetes. The recommendations call for specific guidelines on both lifestyle,...
Twofold Action Urged for Pre-Diabetes WEDNESDAY, July 23 (HealthDay News) -- Lifestyle changes, coupled with a reduction in heart disease risks, will go a long way toward preventing pre-diabetes from progressing to the full-blown disease, experts from the American...
Children's National Medical Center Program Director to Provide Expertise to DiabeTeens.com, The HealthCentral /PRNewswire-USNewswire/ -- The HealthCentral Network, Inc.( www.HealthCentral.com) today announced that Dr.
Fran Cogen, MD, director of the Childhood and Adolescent Diabetes Program at Children's National Medical Center, will...
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorizat -Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced the submission of a New Drug Application (NDA) to the U.S.Food and Drug Administration (FDA) on June 30th and validation of a Marketing Authorization...
Type 2 Diabetes Genetics - Research on type 2 diabetes genetics detailed by scientists at University of Oklaho Learn more about a six-week, no-risk free trial of Diabetes Week We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00.
Research on type 2 diabetes genetics detailed by...
Biodel Announces Publications Demonstrating Superior Metabolic Profile of VIAject Compared to the Rapid-acting - Biodel Inc.(Nasdaq: BIOD) announced today the publication of positive findings from studies demonstrating the superior metabolic profile of VIAject(TM) ultra rapid-acting insulin compared to the rapid-acting analog, Humalog(R), and...
Diabetes - Diabetic Hypoglycaemia: ESP Bioscience Announces New Journal for 2008 July 21st, 2008 ESP Bioscience announced the forthcoming launch of Diabetic Hypoglycaemia an influential new online journal delivering a range of hypoglycaemia information, including: background science, human , and clinical and...
Insulin pump plan lauded Hundreds of locals have Type 1 diabetes Posted By COLIN MCKIM, THE PACKET AND TIMES An Orillia doctor has called news of a government program to provide insulin pumps to 1,300 adult Ontario residents with Type-1 diabetes 'pretty...
Sangamo BioSciences Reports Second Quarter 2008 Financial Results RICHMOND, Calif., July 23 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.today reported second quarter 2008 financial results and accomplishments.
For the second quarter ended June 30, 2008, Sangamo reported a consolidated net loss...
Sangamo BioSciences Reports Second Quarter 2008 Financial Results RICHMOND, Calif., July 23 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.today reported second quarter 2008 financial results and accomplishments.
For the second quarter ended June 30, 2008, Sangamo reported a consolidated net loss...
Diabetes Experts Recommend One-Two Punch for Treating Patients with Pre-Diabetes WASHINGTON--(BUSINESS WIRE)--For the first time, a consensus of diabetes and metabolic disorder experts have recommended a comprehensive treatment regimen for patients with pre-diabetes. The recommendations call for specific...
Diabetes Experts Recommend One-Two Punch for Treating Patients with Pre-Diabetes -For the first time, a consensus of diabetes and metabolic disorder experts have recommended a comprehensive treatment regimen for patients with pre-diabetes. The recommendations call for specific guidelines on both lifestyle,...
Diabetes Experts Recommend One-Two Punch for Treating Patients with Pre-Diabetes For the first time, a consensus of diabetes and metabolic disorder experts have recommended a comprehensive treatment regimen for patients with pre-diabetes. The recommendations call for specific guidelines on both lifestyle,...
An Eye Test for Diabetes A snapshot of the retina could detect cell damage in the early stages of diabetes. Detecting diabetes: A new eye test picks up fluorescence given off by dying cells in the retina, shown here.
Scientists say that the test can...
Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients w Two Regimens Including Lantus(R) and Apidra(R) Resulted in Significant Reductions in A1C in Patients with Type 2 Diabetes, Whatever the Algorithm Used BRIDGEWATER, N.J., July 22, 2008 /PRNewswire/ -- Results from the 'Adjust to Target...
Santarus and Depomed Announce U.S. Promotion Agreement for Glumetza Prescription Products - Santarus, Inc.(NASDAQ: SNTS) and Depomed, Inc.
(NASDAQ: DEPO) today announced that they have entered into a promotion agreement granting Santarus exclusive rights to promote Depomed's GLUMETZA(R) (metformin hydrochloride extended...
Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients w BRIDGEWATER, N.J., July 22 /PRNewswire/ -- Results from the 'Adjust to Target in Type 2 Diabetes: Comparison of a Simple Algorithm to Carbohydrate Counting for Adjustment of Mealtime Insulin Glulisine' study, were published in the...
Diabetes Experts Recommend One-Two Punch for Treating Patients with Pre-Diabetes - For the first time, a consensus of diabetes and metabolic disorder experts have recommended a comprehensive treatment regimen for patients with pre-diabetes. The recommendations call for specific guidelines on both lifestyle,...
Diabetes Experts Recommend One-Two Punch for Treating Patients with Pre-Diabetes WASHINGTON--(BUSINESS WIRE)-- For the first time, a consensus of diabetes and metabolic disorder experts have recommended a comprehensive treatment regimen for patients with pre-diabetes. The recommendations call for specific...
Diabetes Experts Recommend One-Two Punch for Treating Patients with Pre-Diabetes WASHINGTON (Business Wire) -- For the first time, a consensus of diabetes and metabolic disorder experts have recommended a comprehensive treatment regimen for patients with pre-diabetes. The recommendations call for specific...
Pre-diabetes must be treated, doctors urge Diabetes experts created the first recommendations Tuesday for the treatment of people with pre-diabetes in the hopes of curbing the diabetes epidemic.There are now no solid guidelines for diagnosing and managing pre-...
Diabetes Experts Recommend One-Two Punch for Treating Patients with Pre-Diabetes Pre-diabetes is a condition defined by elevated fasting glucose levels or impaired glucose tolerance.According to the Centers for Disease Control (CDC), more than 56 million Americans currently have the condition, which leaves...
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorizat PRINCETON, N.J.& LONDON-- (BUSINESS WIRE) -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced the submission of a New Drug Application (NDA) to the U.S.
Food and Drug Administration (FDA) on...
TopAbstracts in Diabetes 07/22/2008 TopAbstracts in Diabetes are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 7 days.Over 2000 peer-reviewed...
